An experiment gone horribly awry: US researchers helped to infect Guatemalans with syphilis to study disease

November 15, 2012 by Alvin Powell, Harvard University
An experiment gone horribly awry: U.S. researchers helped to infect Guatemalans with syphilis to study disease
The experiments occurred at a time when syphilis was taking a large toll in human life and undermining U.S. troops, Reverby said.

In the late 1940s, U.S. researchers used Guatemalan prisoners, mental patients, and soldiers as laboratory animals, infecting them with syphilis without their knowledge in order to test new treatments for the disease.

The experiments, which came to an end with the development elsewhere of penicillin as a treatment, remained secret until several years ago, when a Wellesley College researcher stumbled upon them while looking into similar cases involving poor African-American men in Tuskegee, Ala.

When news of the experiments came to light in 2010, it sparked an international uproar, claiming headlines and prompting apologies from U.S. Secretary of State and Secretary of Health and Human Services . The news also led to a phone call from President to Guatemalan President Alvaro Colom, who called the experiments "a crime against humanity."

On Tuesday, a Harvard Law School panel discussed the case, highlighting options for reparations and warning against thinking that something similar can't happen again. In fact, one panelist said, new laws in the wake of the 9/11 terrorist attacks, the subsequent anthrax attacks, and outbreaks like H1N1, which were designed to increase protections against liability for disease researchers, could be used to protect those who engage in experiments similar to those in Tuskegee and Guatemala today.

"While we like to think we've learned our lessons from Tuskegee and Guatemala, I'm not sure we have," said Wendy Parmet, a professor and associate dean at Northeastern University's School of Law.

In addition to Parmet, the panel included Susan Reverby, the Wellesley College professor who discovered the documents; I. Glenn Cohen, assistant professor of law and director of Harvard Law School's Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics; Fernando Ribeiro Delgado, at Harvard Law School; and Holly Fernandez Lynch, executive director of the Petrie-Flom Center. The event, which was held in the Wasserstein Building, was sponsored by the center and the Law School's Human Rights Program.

The experiments occurred at a time when syphilis was taking a large toll in human life and undermining U.S. troops, Reverby said. Though the Tuskegee and Guatemala experiments were similar, there was a key difference, Reverby said. In the Tuskegee experiments, researchers withheld treatment but never infected anyone. In those cases, which ran from the 1930s until 1972, African-American men who had the disease were followed to track its course.

In the Guatemalan experiments, however, researchers paid prostitutes who already had syphilis to have sex with the study subjects. The subjects never consented to being infected with the disease and, though some were treated afterward, it is unclear if all were.

Among the thousands of pages of documents and photographs detailing the experiments, there was evidence that the researchers knew what they were doing and knew that it was wrong, Reverby said. The question about how to remedy the situation remains open, panelists said.

In the wake of the revelations, the U.S. government conducted an investigation and took some steps toward making the situation right. The Centers for Disease Control and Prevention and National Institutes of Health pledged funding for programs to fight sexually transmitted diseases in Guatemala, but little was done to compensate the victims, panelists said. In fact, a class action lawsuit on the Guatemalan victims' behalf was dismissed, largely because there are high hurdles for individuals in other countries to sue the U.S. government, even for American actions in their country.

Still, the panelists said, there are other potential avenues, including congressional approval of a settlement, according to Cohen. Other possible avenues include pursuing remedies through the Inter-American Commission on Human Rights or other international bodies.

Explore further: Unethical US research killed 83 in Guatemala: panel

Related Stories

Unethical US research killed 83 in Guatemala: panel

August 29, 2011
At least 83 people died as human guinea pigs in macabre US research on sexually transmitted diseases in Guatemala in the 1940s, a commission ordered by President Barack Obama concluded Monday.

Guatemala finds 5 who survived deadly US research

August 30, 2011
The Guatemalan government said Tuesday it has tracked down five survivors from a deadly US government research project on sexually transmitted diseases that killed scores of its people.

Recommended for you

Best of Last Year—The top Medical Xpress articles of 2017

December 20, 2017
It was a good year for medical research as a team at the German center for Neurodegenerative Diseases, Magdeburg, found that dancing can reverse the signs of aging in the brain. Any exercise helps, the team found, but dancing ...

Pickled in 'cognac', Chopin's heart gives up its secrets

November 26, 2017
The heart of Frederic Chopin, among the world's most cherished musical virtuosos, may finally have given up the cause of his untimely death.

Sugar industry withheld evidence of sucrose's health effects nearly 50 years ago

November 21, 2017
A U.S. sugar industry trade group appears to have pulled the plug on a study that was producing animal evidence linking sucrose to disease nearly 50 years ago, researchers argue in a paper publishing on November 21 in the ...

Female researchers pay more attention to sex and gender in medicine

November 7, 2017
When women participate in a medical research paper, that research is more likely to take into account the differences between the way men and women react to diseases and treatments, according to a new study by Stanford researchers.

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.